Evogene Ltd. (EVGN)

CIK 1574565 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Evogene Ltd..

Recent SEC filings

FiledFormAccession number
Oct 28, 20266-K0001178913-26-004871
Oct 22, 202630001178913-26-004819
Oct 22, 202630001178913-26-004820
Oct 6, 20266-K0001178913-26-004722
Oct 6, 2026SCHEDULE 13D/A0001213900-26-107207
Sep 30, 202640001178913-26-004658
Sep 30, 202640001178913-26-004664
Sep 30, 202640001178913-26-004660
Sep 30, 20266-K0001178913-26-004654
Sep 30, 202640001178913-26-004662
Sep 29, 2026EFFECT9999999995-26-003086
Sep 28, 20266-K0001178913-26-004636
Sep 28, 2026POS AM0001178913-26-004632
Sep 15, 20266-K0001178913-26-004516
Sep 11, 2026SCHEDULE 13D/A0001178913-26-004496
Sep 11, 2026SCHEDULE 13D/A0001213900-26-098957
Sep 4, 20266-K0001178913-26-004425
Aug 28, 2026SCHEDULE 13D/A0001213900-26-094703
Aug 27, 20266-K0001178913-26-004270
Aug 26, 202640001178913-26-004259
Aug 18, 20266-K0001178913-26-004174
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003576
Aug 13, 202640001178913-26-004095
Aug 13, 2026SCHEDULE 13D/A0001213900-26-088987
Aug 13, 2026SCHEDULE 13D/A0001178913-26-004098